Literature DB >> 25733375

Editorial: ADAMs control inflammation from afar.

Robert K Andrews1, Elizabeth E Gardiner2.   

Abstract

Entities:  

Keywords:  G protein-coupled receptors; Neutrophils; chemotaxis; leukocyte; metalloproteinase

Mesh：

Substances：

Year:  2015        PMID： 25733375      PMCID： PMC5477894          DOI： 10.1189/jlb.3CE1114-528R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


× No keyword cloud information.
  12 in total

Review 1.  Who decides when to cleave an ectodomain?

Authors:  Monika Hartmann; Andreas Herrlich; Peter Herrlich
Journal:  Trends Biochem Sci       Date:  2013-01-05       Impact factor: 13.807

2.  Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.

Authors:  M H Khandaker; G Mitchell; L Xu; J D Andrews; R Singh; H Leung; J Madrenas; S S Ferguson; R D Feldman; D J Kelvin
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

Review 3.  Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.

Authors:  Bhawna Sharma; Seema Singh; Michelle L Varney; Rakesh K Singh
Journal:  Expert Opin Ther Targets       Date:  2010-04       Impact factor: 6.902

4.  Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels.

Authors:  Netanel Korin; Mathumai Kanapathipillai; Benjamin D Matthews; Marilena Crescente; Alexander Brill; Tadanori Mammoto; Kaustabh Ghosh; Samuel Jurek; Sidi A Bencherif; Deen Bhatta; Ahmet U Coskun; Charles L Feldman; Denisa D Wagner; Donald E Ingber
Journal:  Science       Date:  2012-07-05       Impact factor: 47.728

5.  Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17).

Authors:  Hemant K Mishra; Chunmei Long; Nooshin S Bahaie; Bruce Walcheck
Journal:  J Leukoc Biol       Date:  2014-11-20       Impact factor: 4.962

Review 6.  CXCR2 modulators: a patent review (2009 - 2013).

Authors:  Michael P Dwyer; Younong Yu
Journal:  Expert Opin Ther Pat       Date:  2014-02-20       Impact factor: 6.674

7.  iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.

Authors:  Priya Darshinee A Issuree; Thorsten Maretzky; David R McIlwain; Sébastien Monette; Xiaoping Qing; Philipp A Lang; Steven L Swendeman; Kyung-Hyun Park-Min; Nikolaus Binder; George D Kalliolias; Anna Yarilina; Keisuke Horiuchi; Lionel B Ivashkiv; Tak W Mak; Jane E Salmon; Carl P Blobel
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

8.  Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases.

Authors:  E E Gardiner; D Karunakaran; Y Shen; J F Arthur; R K Andrews; M C Berndt
Journal:  J Thromb Haemost       Date:  2007-04-18       Impact factor: 5.824

Review 9.  Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases.

Authors:  Nithin B Boppana; Asokan Devarajan; Kaliappan Gopal; Muttiah Barathan; Sazaly A Bakar; Esaki M Shankar; Abdul S Ebrahim; Shukkur M Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-13

10.  Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease.

Authors:  Dominik Hartl; Philipp Latzin; Peter Hordijk; Veronica Marcos; Carsten Rudolph; Markus Woischnik; Susanne Krauss-Etschmann; Barbara Koller; Dietrich Reinhardt; Adelbert A Roscher; Dirk Roos; Matthias Griese
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.